Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide and Glucagon for Glucose Control in Children with T1D
NCT00206258Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2002
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pramlintide, glucagon in type 1 diabetes mellitus (T1D), sponsored by Baylor College of Medicine. Started Jul 2002; status: completed.
02
Drugs
pramlintideglucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00206258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206258.